Topical Bioavailability

Topical Bioavailability is the fraction of a topically applied drug that reaches the systemic circulation or target site in an active form, distinguishing it from other pharmacokinetic measures by specifically accounting for the drug's absorption and local disposition following non-systemic administration in pediatric dermatotherapeutics.

161

Publications

6.6K

Citations

653

Authors

247

Institutions

Publications per year

2017–2026

38

Authors

653

  1. RH
    Richard H. Guy

    University of California, San Francisco, United States

    10 publications · 540 citations

    10

    h-index

  2. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    7 publications · 524 citations

    7

    h-index

  3. MB
    M. Begoña Delgado‐Charro

    University of Bath, United Kingdom

    6 publications · 328 citations

    6

    h-index

  4. WI
    William I. Higuchi

    University of Utah, United States

    5 publications · 143 citations

    5

    h-index

  5. TF
    Thomas Franz

    University of Cape Town, South Africa

    5 publications · 338 citations

    5

    h-index

1–5 of 653

Venues

  1. International Journal of Pharmaceutics

    15 publications · 955 citations

    15

    h-index

  2. Pharmaceutical Research

    12 publications · 596 citations

    12

    h-index

  3. Journal of Pharmaceutical Sciences

    8 publications · 277 citations

    8

    h-index

  4. Skin Pharmacology and Physiology

    8 publications · 377 citations

    8

    h-index

  5. Journal of Investigative Dermatology

    JID · 7 publications · 490 citations

    7

    h-index

1–5